OK You scared me. I took a loss and am out

Just got off Geron webcast zzzzz

Potential Strategic buy out by Geron? Advanced Cell is obviously the leader. Thoughts?

Question to the board..So the ASk was set at 24 when the last price was 22 for atleast about 20 minutes before the last went up to 23. This was on my ameritrade account.

Did they make a best case guess or would it have been based on MM activity? any thoughts?

Alright Guys. VOLT is on its way to the USA

GSLO's First Shipment of Volt Solar Chargers En Route to U.S.Last update: 4/19/2011 9:00:09 AMCutting-Edge Battery Pack Charges Apple iPhone Using Solar Energy NEW ORLEANS, Apr 19, 2011 (BUSINESS WIRE) -- GoSolarUSA (pinksheets:GSLO) announced today that its initial shipment of Volt Solar Charger accessories for the Apple iPhone is en route from the manufacturer in China to the United States. The shipment's arrival represents the culmination of months of work by GoSolarUSA to bring the cutting-edge solar technology to the U.S. The Volt Solar Charger is a new detachable smartphone accessory designed to dramatically extend the Apple iPhone's battery life using a top-of-the-line, built-in solar panel and a 1500 mAh rechargeable battery. Developed by Xiamen Solar Electronics (XSE), the Volt is the only iPhone battery pack known to GSLO capable of recharging the iPhone 3, iPhone 3GS and iPhone 4 with the same device. Earlier this year, GoSolarUSA signed a distribution agreement with XSE providing GSLO with the exclusive right to sell and distribute the Volt in North America, the world's largest market for iPhone accessories. "We couldn't be more pleased that the Volt is on its way to America at last," said GSLO President and CEO Tyson Rohde. "I've received the initial shipment's DHL tracking number, and we expect it to arrive in the next couple of weeks. Based on the interest we've received in the device over the past few months, this first shipment will not last long." The exploding demographics of iPhone users in the U.S. has led to unprecedented demand for smartphone accessories such as the Volt Solar Charger, Rohde said. In January, GoSolarUSA unveiled a Volt waiting list and giveaway on its Web site to allow consumers to sign up to be notified first when the Volt Solar Charger becomes available in North America. To encourage potential customers to reserve a Volt Solar Charger, GoSolarUSA will give away a Volt to 100 randomly selected people who sign up for the device's waiting list with no purchase necessary. "With the first Volt units soon to arrive, we plan to close the waiting list shortly and announce the winners of our Volt giveaway," Rohde said. "Anyone waiting until the last minute to sign up would be wise to do so quickly." To sign up for GoSolarUSA's Volt waiting list and giveaway, please visit . GoSolarUSA is dedicated to aggressively acquiring, developing and marketing promising and potentially profitable technology. The Volt Solar Charger is a product of Xiamen Solar Electronics based in Xiamen, China. The iPhone is a product of Apple Inc. (AAPL), which competes in the global mobile electronics market against Motorola Mobility Holdings, Inc. (MMI) and Research in Motion (RIMM). For more information, please visit . About GoSolarUSA, Inc. GoSolarUSA primarily identifies and develops new solar energy technologies in the United States. We believe this not only creates high-quality jobs in America, but also ensures the quality and availability of our products. GSLO is endeavoring to advance clean American solar technology to compete in an energy industry that includes stalwarts such as First Solar (FSLR). GoSolarUSA is a US registered and reporting OTCQB market tier company. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "should," "plans," "believes," "expects," "aims," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof. SOURCE: GoSolarUSA
GoSolarUSA, Inc. President and CEO Tyson Rohde, 504-599-5979 info@gosolarusa.comCopyright Business Wire 2011
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.

Can someone help me understand this? Is something big about to happen to this company?

Cell Therapeutics and Sunesis Eager to Earn Blockbuster Status
8:16a ET April 12, 2011 (Market Wire)
There is plenty of optimism surrounding the biotech sector as firmer pricing and new products have improved sales and earnings trends. Meanwhile, younger, more speculative firms continue to garner significant attention with potential blockbuster products working their way through the regulatory process. The Bedford Report examines the outlook for companies in the Biotechnology Industry and provides research reports on Cell Therapeutics, Inc. (NASDAQ: CTIC) and Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS). Access to the full company reports can be found at:

www.bedfordreport.com/2011-04-CTIC

www.bedfordreport.com/2011-04-SNSS

IMS Health, a leading research and analytical firm serving the pharmaceutical and medical industries, projects an increase in worldwide biotech growth in 2011 of between 5 and 7 percent, with a similar outlook stretching out to 2015. Emerging markets such as China, India, and Brazil are expected to contribute significantly to this growth. Sales growth of 15 percent is forecast in emerging markets, many of which are benefitting from increased government spending on healthcare and broader private health coverage for workers.

The Bedford Report releases regular market updates on the Healthcare Sector so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.

Cell Therapeutics recently said that it will spend $10 million to buy rights to an anti-cancer drug owned by Chroma Therapeutics. Cell Therapeutics said that in trials, Chroma's drug had "demonstrated significant anti-tumor responses in blood related cancers and solid tumors."

Cell Therapeutics has its own potential blockbuster drug working its way through the regulatory process. Although the company's "pixantrone" drug for non-Hodgkin's lymphoma failed to gain FDA approval last year, CTIC is preparing to start a new clinical trial of the drug.

The Bedford Report provides Analyst Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned publicly traded companies. The Bedford Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.bedfordreport.com/disclaimer

Contact:
The Bedford Report
Email Contact





SOURCE: The Bedford Report

http://www2.marketwire.com/mw/emailprcntct?id=783EA9BABB9DD684

http://www.sec.gov/Archives/edgar/data/1398522/000114420411001464/v207710_8k.htm

Thx for lookin' out for me Black Cat. I'll be careful

Thank You Buddy. I am watching it very closely. Not letting it out of my sight.

IMO this stock will run when news of VOLT completion and shipment to US is released. It has stayed pretty steady between 27 and 29 for a while now. A little more patience will pay off

:) Sure we all want PR today. But imo its unlikely they would do a PR on a friday and lose momentum over the weekend. I hope they have something for us early next week

Averages have been down across the board today. Despite that TADF has given us some action. Stick around have patience. Its gonna be big for us.

Financials are down today across the board. I don't see anything abnormal with this stock. I am loading up more

Going up again..let it go guys don't kill it.

Greetings Wild. I loaded 90K. It can only go north from here